I agree that this site is using cookies. You can find further informations here.
X
Casteele, N
84  results:
Search for persons X
?
1

OP10 Importance of trough levels and antibodies on the long..:

Arias, M.T. ; Van de Casteele, N. ; Drobne, D....
Journal of Crohn's and Colitis.  6 (2012)  - p. S5 , 2012
Link: https://doi.org/10.1016/..
 
?
2

P253 Transient versus sustained antibodies to infliximab: P..:

Van de Casteele, N. ; Cuypers, L. ; Singh, S....
Journal of Crohn's and Colitis.  6 (2012)  - p. S110 , 2012
Link: https://doi.org/10.1016/..
 
?
3

Oralité et langage:

Van de Casteele, N ; Mokhtari, M ; Gosme-Séguret, S.
Journal de Pédiatrie et de Puériculture.  11 (1998)  1 - p. 39-42 , 1998
Link: https://doi.org/10.1016/..
 
?
4

Characterization of a new HLA‐B39 allele, B*3913, in a Braz..:

Maertens, R. ; De Canck, I. ; Moraes, M.E....
Tissue Antigens.  52 (1998)  6 - p. 583-586 , 1998
Link: https://doi.org/10.1111/..
 
?
5

Letter: dose optimising infliximab in acute severe ulcerati..:

Jairath, V. ; Casteele, N. V. ; Hindryckx, P.
Alimentary Pharmacology & Therapeutics.  45 (2017)  8 - p. 1170-1171 , 2017
Link: https://doi.org/10.1111/..
 
?
6

Relation entre la concentration plasmatique de certolizumab..:

Goupille, P. ; Wolbink, G. ; Sandborn, W....
Revue du Rhumatisme.  83 (2016)  - p. A46-A47 , 2016
Link: https://doi.org/10.1016/..
 
?
7

OP40 Transcriptomic signature of response to vedolizumab in..:

Linggi, B ; Salas, A ; Veny, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i71-i71 , 2024
Link: https://doi.org/10.1093/..
 
?
8

P928 "Metabolism and Response to Stress" (MARS) gene signat..:

Linggi, B ; Sangiorgi, B ; Smith, M I...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1687-i1688 , 2024
Link: https://doi.org/10.1093/..
 
?
9

DOP35 Spatial transcriptomics reveals cellular niches assoc..:

Battat, R ; Sangiorgi, B ; Linggi, B...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i135-i136 , 2024
Link: https://doi.org/10.1093/..
 
?
10

P479 Reliability and responsiveness of histologic disease a..:

Solitano, V ; Schaeffer, D F ; Hogan, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i608-i609 , 2023
Link: https://doi.org/10.1093/..
 
?
11

P306 MORF-057, an oral selective α4β7 integrin inhibitor fo..:

Ray, A ; Cui, D ; Lee, D...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S333-S335 , 2021
Link: https://doi.org/10.1093/..
 
?
12

P540 GB004, a novel prolyl hydroxylase inhibitor for inflam..:

Levesque, B ; Taylor Meadows, K ; Buch, A...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S461-S462 , 2020
Link: https://doi.org/10.1093/..
 
?
13

P120 Prevalence of endoscopic improvement and endoscopic re..:

Dulai, P ; Singh, S ; Jairath, V...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S196-S196 , 2020
Link: https://doi.org/10.1093/..
 
?
14

DOP45 Adequate infliximab exposure during the induction pha..:

Vande Casteele, N ; Papamichael, K ; Jeyarajah, J..
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S053-S054 , 2019
Link: https://doi.org/10.1093/..
 
?
15

P485 Prediction Model Incorporating Pharmacokinetics Calcul..:

Vande Casteele, N ; Jairath, V ; Jeyarajah, J...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S354-S355 , 2019
Link: https://doi.org/10.1093/..
 
1-15